Policy commitments on lung cancer are growing. But in too many countries, the gap between commitment and implementation is wide, held back by limited policy engagement and persistent challenges in securing sustainable funding.
At this year’s World Conference on Lung Cancer (WCLC), the Network will host two sessions designed bridge this gap: one focused on the skills needed to influence policy, and the other on the financing and delivery of lung cancer priorities in practice.
Both sessions are open to WCLC registrants, and aimed at healthcare professionals, advocates and researchers. Places are limited so register now to avoid disappointment.
From evidence to action: practical skills for engaging policymakers on earlier lung cancer detection
12 September 2026 | 08:00–10:00 KST
An interactive, skills-based workshop equipping participants to engage policymakers with confidence. Through applied exercises and real-world scenarios, attendees will learn how to translate evidence into clear policy messages and develop targeted policy asks that resonate with decision-makers.
Financing the implementation of lung cancer policy: the critical role of experts and advocates
14 September 2026 | 15:30–16:45 KST
A session examining how lung cancer priorities are funded in practice. Drawing on global experience, it will explore how countries are moving from commitments to implementation, and what healthcare professionals and advocates can do to make the case for sustainable investment.
Recent news
News
Delays in lung cancer care addressed in new policy brief on timed targets
Timed targets set time frames for diagnosis, treatment and other aspects of care, and are a practical way to improve outcomes and accountability.
Case study
A radiology-led model for LDCT in Norway: the first pilot programme
Norway’s pilot programme stands out for its radiology-led model, which substantially reduced the workload for respiratory services.
News
Webinar to examine the role of timed targets in improving lung cancer care
At our free webinar on Monday 13 July, a global panel of clinicians, professors and patient advocates will share their perspectives on how timed targets can support better, more equitable lung cancer care.